November 2004

J Psychiatry Neurosci 2004;29(6)

Editorial

Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder?
J.M. Le Mellédo, N. Mahil, G.B. Baker

Review Papers

The role of the hippocampus in the pathophysiology of major depression
S. Campbell, G. MacQueen

Interactions between ß-amyloid and central cholinergic neurons: implications for Alzheimer’s disease
S. Kar, S.P.M. Slowikowski, D. Westaway, H.T.J. Mount

Research Paper

Testing the association between thyroid dysfunction and psychiatric diagnostic group in an iodine-deficient area
D. Hermann, W. Hewer, F. Lederbogen

Potential benefits of quetiapine in the treatment of substance dependence disorders
S.P Sattar, S.C. Bhatia, F. Petty

Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission
G. Tringali, J.M. Aubry, K. Moscianese, C. Zamori, M. Vairano, P. Preziosi, P. Navarra, G. Pozzoli

Brief Report

Tardive dyskinesia in 2 patients treated with ziprasidone
J. Ananth, K.S. Burgoyne, D. Niz, M. Smith

CCNP News and Views

The 27th Annual Meeting of the Canadian College of Neuropsychopharmacology, Kingston, Ontario, Canada, May 29 to June 1, 2004
C. Flores, T. Paine, L.K. Srivastava, M. Leyton

Psychopharmacology for the Clinician

Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs?
S. Kanba